181 related articles for article (PubMed ID: 8803528)
21. Pharmacokinetics of cefetamet in plasma and skin blister fluid.
Zimmerli W; Sansano S; Wittke B
Antimicrob Agents Chemother; 1996 Jan; 40(1):102-4. PubMed ID: 8787888
[TBL] [Abstract][Full Text] [Related]
22. Penetration of Pazufloxacin into the Fluid of Suction Blisters Induced in Human Skin.
Totsuka K; Tei M; Kodama K; Yafune A
J Infect Chemother; 1996; 2(4):280-282. PubMed ID: 29681382
[TBL] [Abstract][Full Text] [Related]
23. Population pharmacokinetic analysis and optimization of the experimental design for mizolastine solution in children.
Mentré F; Dubruc C; Thénot JP
J Pharmacokinet Pharmacodyn; 2001 Jun; 28(3):299-319. PubMed ID: 11468942
[TBL] [Abstract][Full Text] [Related]
24. Lack of interaction between two antihistamines, mizolastine and cetirizine, and ethanol in psychomotor and driving performance in healthy subjects.
Patat A; Stubbs D; Dunmore C; Ulliac N; Sexton B; Zieleniuk I; Irving A; Jones W
Eur J Clin Pharmacol; 1995; 48(2):143-50. PubMed ID: 7589029
[TBL] [Abstract][Full Text] [Related]
25. Anti-inflammatory properties of mizolastine after oral administration on arachidonic acid-induced cutaneous reaction in the rat.
Pichat P; Angel I; Arbilla S
Arzneimittelforschung; 1998 Feb; 48(2):173-8. PubMed ID: 9541729
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of oritavancin in plasma and skin blister fluid following administration of a 200-milligram dose for 3 days or a single 800-milligram dose.
Fetterly GJ; Ong CM; Bhavnani SM; Loutit JS; Porter SB; Morello LG; Ambrose PG; Nicolau DP
Antimicrob Agents Chemother; 2005 Jan; 49(1):148-52. PubMed ID: 15616289
[TBL] [Abstract][Full Text] [Related]
27. Measurement of interstitial cetirizine concentrations in human skin: correlation of drug levels with inhibition of histamine-induced skin responses.
Petersen LJ; Church MK; Rihoux JP; Skov PS
Allergy; 1999 Jun; 54(6):607-11. PubMed ID: 10435475
[TBL] [Abstract][Full Text] [Related]
28. Dose-response relationship between objective measures of histamine-induced weals and dose of terfenadine.
Shall L; Newcombe RG; Lush M; Marks R
Acta Derm Venereol; 1991; 71(3):199-204. PubMed ID: 1678220
[TBL] [Abstract][Full Text] [Related]
29. Ketoconazole concentrations in human skin blister fluid and plasma.
Schäfer-Korting M; Korting HC; Dorn M; Mutschler E
Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):371-4. PubMed ID: 6088407
[TBL] [Abstract][Full Text] [Related]
30. Microdialysis vs. suction blister technique for in vivo sampling of pharmacokinetics in the human dermis.
Benfeldt E; Serup J; Menné T
Acta Derm Venereol; 1999 Sep; 79(5):338-42. PubMed ID: 10494706
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of ceftazidime in serum and suction blister fluid during continuous and intermittent infusions in healthy volunteers.
Mouton JW; Horrevorts AM; Mulder PG; Prens EP; Michel MF
Antimicrob Agents Chemother; 1990 Dec; 34(12):2307-11. PubMed ID: 2088186
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of cefpodoxime in plasma and skin blister fluid following oral dosing of cefpodoxime proxetil.
Borin MT; Hughes GS; Spillers CR; Patel RK
Antimicrob Agents Chemother; 1990 Jun; 34(6):1094-9. PubMed ID: 2393268
[TBL] [Abstract][Full Text] [Related]
33. Suction-induced blister fluid penetration of cefdinir in healthy volunteers following ascending oral doses.
Richer M; Allard S; Manseau L; Vallée F; Pak R; LeBel M
Antimicrob Agents Chemother; 1995 May; 39(5):1082-6. PubMed ID: 7625793
[TBL] [Abstract][Full Text] [Related]
34. Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetration.
Barbhaiya RH; Shukla UA; Gleason CR; Shyu WC; Wilber RB; Pittman KA
Antimicrob Agents Chemother; 1990 Jun; 34(6):1204-9. PubMed ID: 2393282
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of dalbavancin in plasma and skin blister fluid.
Nicolau DP; Sun HK; Seltzer E; Buckwalter M; Dowell JA
J Antimicrob Chemother; 2007 Sep; 60(3):681-4. PubMed ID: 17631507
[TBL] [Abstract][Full Text] [Related]
36. QT interval monitoring during clinical studies with mizolastine, a new H1 antihistamine.
Delauche-Cavallier MC; Chaufour S; Guérault E; Lacroux A; Murrieta M; Wajman A
Clin Exp Allergy; 1999 Jul; 29 Suppl 3():206-11. PubMed ID: 10444239
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of ampicillin in serum and in dermal suction blisters after oral administration of bacampicillin.
Schreiner A; Bergan T; Hellum KB; Digranes A
Rev Infect Dis; 1981; 3(1):125-31. PubMed ID: 7221355
[TBL] [Abstract][Full Text] [Related]
38. Levels of itraconazole in skin blister fluid after a single oral dose and during repetitive administration.
Schäfer-Korting M; Korting HC; Lukacs A; Heykants J; Behrendt H
J Am Acad Dermatol; 1990 Feb; 22(2 Pt 1):211-5. PubMed ID: 2155951
[TBL] [Abstract][Full Text] [Related]
39. Study of cardiac repolarization in healthy volunteers performed with mizolastine, a new H1-receptor antagonist.
Chaufour S; Caplain H; Lilienthal N; L'héritier C; Deschamps C; Dubruc C; Rosenzweig P
Br J Clin Pharmacol; 1999 May; 47(5):515-20. PubMed ID: 10336575
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetic and pharmacodynamic studies of the histamine H1-receptor antagonist ebastine in dogs.
Puigdemont A; Queralt M; Jansat JM; Martinez-Tobed A
J Pharm Pharmacol; 1994 Jul; 46(7):596-9. PubMed ID: 7996390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
